Contraception is an important consideration for many individuals and couples. As technology advances, so does the availability of new methods of contraception. One of the most recent developments is Nexplanon, a long-acting reversible contraceptive (LARC) that is inserted under the skin of the upper arm. This article will explore the benefits of Nexplanon and discuss the implications for the future of contraception.
Nexplanon is a type of LARC, which is a form of contraception that is inserted under the skin of the upper arm and can remain effective for up to three years. It is a small, flexible rod that is inserted just beneath the skin and releases progestin, a hormone that prevents pregnancy. It is a highly effective form of contraception, with a failure rate of less than 1%. Unlike other forms of contraception, such as the pill, Nexplanon does not require daily or weekly maintenance and does not interfere with sexual activity.
Nexplanon offers many benefits to users, including:
The development of Nexplanon has implications for the future of contraception. As a highly effective form of contraception that is easy to use and does not interfere with sexual activity, Nexplanon is likely to become increasingly popular in the future. Furthermore, the development of LARCs such as Nexplanon could lead to the development of other long-acting contraceptives, such as implants and intrauterine devices, which could offer even greater convenience and effectiveness.
Nexplanon is a highly effective form of contraception that offers many benefits to users. It is easy to use, does not interfere with sexual activity, and can remain effective for up to three years. The development of Nexplanon has implications for the future of contraception, as it could lead to the development of other long-acting contraceptives that offer even greater convenience and effectiveness.
1.
Australian researchers attribute drop in melanoma rates to increasingly diverse population
2.
Scientists discover the 'roadmap' that aggressive cancer uses to spread
3.
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
4.
Unprecedented PFS in HER2-Mutant Lung Cancer, but With a Touch of Controversy
5.
Scientists pioneer noninvasive 3D imaging to enhance skin cancer management
1.
CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights
2.
Geriatric Assessment Before Systemic Cancer Therapy: Clinical Relevance and Evidence-Based Approaches
3.
The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future
4.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
5.
Chronic Disease Clustering in Communities: Epidemiology, Mechanisms, and Clinical Implications
1.
International Conference on Cancer Nursing and Rehabilitation Strategies
2.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
3.
International Conference on Innovations in Critical Care for Oncology and Cardiology
4.
International Symposium on Oncology, Cardiology and Critical Care Innovations
5.
International Conference on Cancer Nursing and Hematology Support
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation